Cargando…

COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA

In a Plenary Paper, Mittelman and colleagues assess the relative clinical efficacy of mRNA vaccination on COVID-19 disease incidence and outcomes in patients with hematologic malignancies compared with healthy matched controls. This population-based study from Israel links prior observations of poor...

Descripción completa

Detalles Bibliográficos
Autores principales: Pagano, Livio, Salmanton-García, Jon, Marchesi, Francesco, López-García, Alberto, Lamure, Sylvain, Itri, Federico, Gomes-Silva, Maria, Dragonetti, Giulia, Falces-Romero, Iker, van Doesum, Jaap, Sili, Uluhan, Labrador, Jorge, Calbacho, Maria, Bilgin, Yavuz M., Weinbergerová, Barbora, Serrano, Laura, Ribera-Santa Susana, José-María, Malak, Sandra, Loureiro-Amigo, José, Glenthøj, Andreas, Córdoba-Mascuñano, Raúl, Nunes-Rodrigues, Raquel, González-López, Tomás-José, Karlsson, Linda Katharina, Jiménez-Lorenzo, María-Josefa, Hernández-Rivas, José-Ángel, Jaksic, Ozren, Ráčil, Zdeněk, Busca, Alessandro, Corradini, Paolo, Hoenigl, Martin, Klimko, Nikolai, Koehler, Philipp, Pagliuca, Antonio, Passamonti, Francesco, Cornely, Oliver A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577877/
https://www.ncbi.nlm.nih.gov/pubmed/34748627
http://dx.doi.org/10.1182/blood.2021014124
_version_ 1784596152599969792
author Pagano, Livio
Salmanton-García, Jon
Marchesi, Francesco
López-García, Alberto
Lamure, Sylvain
Itri, Federico
Gomes-Silva, Maria
Dragonetti, Giulia
Falces-Romero, Iker
van Doesum, Jaap
Sili, Uluhan
Labrador, Jorge
Calbacho, Maria
Bilgin, Yavuz M.
Weinbergerová, Barbora
Serrano, Laura
Ribera-Santa Susana, José-María
Malak, Sandra
Loureiro-Amigo, José
Glenthøj, Andreas
Córdoba-Mascuñano, Raúl
Nunes-Rodrigues, Raquel
González-López, Tomás-José
Karlsson, Linda Katharina
Jiménez-Lorenzo, María-Josefa
Hernández-Rivas, José-Ángel
Jaksic, Ozren
Ráčil, Zdeněk
Busca, Alessandro
Corradini, Paolo
Hoenigl, Martin
Klimko, Nikolai
Koehler, Philipp
Pagliuca, Antonio
Passamonti, Francesco
Cornely, Oliver A.
author_facet Pagano, Livio
Salmanton-García, Jon
Marchesi, Francesco
López-García, Alberto
Lamure, Sylvain
Itri, Federico
Gomes-Silva, Maria
Dragonetti, Giulia
Falces-Romero, Iker
van Doesum, Jaap
Sili, Uluhan
Labrador, Jorge
Calbacho, Maria
Bilgin, Yavuz M.
Weinbergerová, Barbora
Serrano, Laura
Ribera-Santa Susana, José-María
Malak, Sandra
Loureiro-Amigo, José
Glenthøj, Andreas
Córdoba-Mascuñano, Raúl
Nunes-Rodrigues, Raquel
González-López, Tomás-José
Karlsson, Linda Katharina
Jiménez-Lorenzo, María-Josefa
Hernández-Rivas, José-Ángel
Jaksic, Ozren
Ráčil, Zdeněk
Busca, Alessandro
Corradini, Paolo
Hoenigl, Martin
Klimko, Nikolai
Koehler, Philipp
Pagliuca, Antonio
Passamonti, Francesco
Cornely, Oliver A.
author_sort Pagano, Livio
collection PubMed
description In a Plenary Paper, Mittelman and colleagues assess the relative clinical efficacy of mRNA vaccination on COVID-19 disease incidence and outcomes in patients with hematologic malignancies compared with healthy matched controls. This population-based study from Israel links prior observations of poor serologic responses to vaccination to higher risk for breakthrough infection, hospitalization, and death in patients with blood cancer, especially those on active antineoplastic therapy. In an accompanying Letter to Blood, Pagano et al provide supportive data using a multination survey approach to capture outcomes for COVID-19 in vaccinated patients with hematologic neoplasms. They also emphasize the higher risk among patients with lymphoid malignancies. Together, these findings argue for both continued deployment of booster programs and ongoing public health guidance for this vulnerable group.
format Online
Article
Text
id pubmed-8577877
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society of Hematology
record_format MEDLINE/PubMed
spelling pubmed-85778772021-11-10 COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA Pagano, Livio Salmanton-García, Jon Marchesi, Francesco López-García, Alberto Lamure, Sylvain Itri, Federico Gomes-Silva, Maria Dragonetti, Giulia Falces-Romero, Iker van Doesum, Jaap Sili, Uluhan Labrador, Jorge Calbacho, Maria Bilgin, Yavuz M. Weinbergerová, Barbora Serrano, Laura Ribera-Santa Susana, José-María Malak, Sandra Loureiro-Amigo, José Glenthøj, Andreas Córdoba-Mascuñano, Raúl Nunes-Rodrigues, Raquel González-López, Tomás-José Karlsson, Linda Katharina Jiménez-Lorenzo, María-Josefa Hernández-Rivas, José-Ángel Jaksic, Ozren Ráčil, Zdeněk Busca, Alessandro Corradini, Paolo Hoenigl, Martin Klimko, Nikolai Koehler, Philipp Pagliuca, Antonio Passamonti, Francesco Cornely, Oliver A. Blood Letters to Blood In a Plenary Paper, Mittelman and colleagues assess the relative clinical efficacy of mRNA vaccination on COVID-19 disease incidence and outcomes in patients with hematologic malignancies compared with healthy matched controls. This population-based study from Israel links prior observations of poor serologic responses to vaccination to higher risk for breakthrough infection, hospitalization, and death in patients with blood cancer, especially those on active antineoplastic therapy. In an accompanying Letter to Blood, Pagano et al provide supportive data using a multination survey approach to capture outcomes for COVID-19 in vaccinated patients with hematologic neoplasms. They also emphasize the higher risk among patients with lymphoid malignancies. Together, these findings argue for both continued deployment of booster programs and ongoing public health guidance for this vulnerable group. American Society of Hematology 2022-03-10 /pmc/articles/PMC8577877/ /pubmed/34748627 http://dx.doi.org/10.1182/blood.2021014124 Text en © 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
spellingShingle Letters to Blood
Pagano, Livio
Salmanton-García, Jon
Marchesi, Francesco
López-García, Alberto
Lamure, Sylvain
Itri, Federico
Gomes-Silva, Maria
Dragonetti, Giulia
Falces-Romero, Iker
van Doesum, Jaap
Sili, Uluhan
Labrador, Jorge
Calbacho, Maria
Bilgin, Yavuz M.
Weinbergerová, Barbora
Serrano, Laura
Ribera-Santa Susana, José-María
Malak, Sandra
Loureiro-Amigo, José
Glenthøj, Andreas
Córdoba-Mascuñano, Raúl
Nunes-Rodrigues, Raquel
González-López, Tomás-José
Karlsson, Linda Katharina
Jiménez-Lorenzo, María-Josefa
Hernández-Rivas, José-Ángel
Jaksic, Ozren
Ráčil, Zdeněk
Busca, Alessandro
Corradini, Paolo
Hoenigl, Martin
Klimko, Nikolai
Koehler, Philipp
Pagliuca, Antonio
Passamonti, Francesco
Cornely, Oliver A.
COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA
title COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA
title_full COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA
title_fullStr COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA
title_full_unstemmed COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA
title_short COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA
title_sort covid-19 in vaccinated adult patients with hematological malignancies: preliminary results from epicovideha
topic Letters to Blood
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577877/
https://www.ncbi.nlm.nih.gov/pubmed/34748627
http://dx.doi.org/10.1182/blood.2021014124
work_keys_str_mv AT paganolivio covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha
AT salmantongarciajon covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha
AT marchesifrancesco covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha
AT lopezgarciaalberto covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha
AT lamuresylvain covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha
AT itrifederico covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha
AT gomessilvamaria covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha
AT dragonettigiulia covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha
AT falcesromeroiker covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha
AT vandoesumjaap covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha
AT siliuluhan covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha
AT labradorjorge covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha
AT calbachomaria covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha
AT bilginyavuzm covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha
AT weinbergerovabarbora covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha
AT serranolaura covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha
AT riberasantasusanajosemaria covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha
AT malaksandra covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha
AT loureiroamigojose covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha
AT glenthøjandreas covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha
AT cordobamascunanoraul covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha
AT nunesrodriguesraquel covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha
AT gonzalezlopeztomasjose covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha
AT karlssonlindakatharina covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha
AT jimenezlorenzomariajosefa covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha
AT hernandezrivasjoseangel covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha
AT jaksicozren covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha
AT racilzdenek covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha
AT buscaalessandro covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha
AT corradinipaolo covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha
AT hoeniglmartin covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha
AT klimkonikolai covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha
AT koehlerphilipp covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha
AT pagliucaantonio covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha
AT passamontifrancesco covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha
AT cornelyolivera covid19invaccinatedadultpatientswithhematologicalmalignanciespreliminaryresultsfromepicovideha